P513 Disparity between infliximab trough level and infliximab associated adverse events
Autor: | Huang, V.W., Dhami, N., Fedorak, D.K., Prosser, C., Shalapay, C., Kroeker, K.I., Fedorak, R.N. |
---|---|
Zdroj: | In Journal of Crohn's and Colitis February 2014 8 Supplement 1:S282-S282 |
Databáze: | ScienceDirect |
Externí odkaz: |